Today the American Kratom Association applauded Secretary Robert Kennedy and FDA Commissioner Dr. Marty Makary for their decisive and science-driven recommendation to classify 7-hydroxymitragynine (7-OH) as a Schedule I substance under the federal Controlled Substances Act. This bold step is a critical milestone in protecting public health and consumer safety from dangerous synthetic products that masquerade as natural kratom.
“Secretary Kennedy and Commissioner Makary have shown exceptional leadership in confronting one of the most urgent public health threats related to mislabeled, manipulated psychoactive substances,” said Mac Haddow, senior fellow on public policy for the American Kratom Association. “These 7-OH products are not kratom. They are chemically altered substances that carry potent opioid-like effects and pose an imminent threat to consumers. This move sends a clear and long-overdue message: the safety of the American public comes first.”
